51 related articles for article (PubMed ID: 11121656)
1. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
2. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy.
Eke I; Aryankalayil MJ; Bylicky MA; Sandfort V; Vanpouille-Box C; Nandagopal S; Graves EE; Giaccia AJ; Coleman CN
Cancer Immunol Immunother; 2022 Apr; 71(4):839-850. PubMed ID: 34435232
[TBL] [Abstract][Full Text] [Related]
3. Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.
Eke I; Makinde AY; Aryankalayil MJ; Reedy JL; Citrin DE; Chopra S; Ahmed MM; Coleman CN
Mol Cancer Res; 2018 Dec; 16(12):1855-1864. PubMed ID: 30042176
[TBL] [Abstract][Full Text] [Related]
4. The anti-tumoral role of Hesperidin and Aprepitant on prostate cancer cells through redox modifications.
Akbari S; Assaran Darban R; Javid H; Esparham A; Hashemy SI
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3559-3567. PubMed ID: 37249616
[TBL] [Abstract][Full Text] [Related]
5. Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells.
Wu Y; Liu P; Chen W; Bai S; Chen S; Chen J; Xu X; Xia J; Wu Y; Lai J; Sun C; Lao Z; Wan X; Wu Z
Int J Hyperthermia; 2024; 41(1):2335201. PubMed ID: 38583875
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.
Shimada H; Matsubara H; Shiratori T; Shimizu T; Miyazaki S; Okazumi S; Nabeya Y; Shuto K; Hayashi H; Tanizawa T; Nakatani Y; Nakasa H; Kitada M; Ochiai T
Cancer Sci; 2006 Jun; 97(6):554-61. PubMed ID: 16734736
[TBL] [Abstract][Full Text] [Related]
7. Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines.
Seim I; Jeffery PL; Thomas PB; Nelson CC; Chopin LK
G3 (Bethesda); 2017 Jun; 7(6):1731-1741. PubMed ID: 28413162
[TBL] [Abstract][Full Text] [Related]
8. Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy.
Makinde AY; John-Aryankalayil M; Palayoor ST; Cerna D; Coleman CN
Mol Cancer Res; 2013 Jan; 11(1):5-12. PubMed ID: 23175523
[TBL] [Abstract][Full Text] [Related]
9. Induction of Apoptosis and Growth Suppression by Homeobox Gene TGIFLX in Prostate Cancer Cell Line Lncap.
Rashvand Z; Heidari M; Raoofian R; Modarresi MH; Shirkoohi R
Iran J Public Health; 2013 Nov; 42(11):1242-52. PubMed ID: 26171336
[TBL] [Abstract][Full Text] [Related]
10. Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models.
Eckert F; Schmitt J; Zips D; Krueger MA; Pichler BJ; Gillies SD; Strittmatter W; Handgretinger R; Schilbach K
Cancer Immunol Immunother; 2016 Aug; 65(8):1003-13. PubMed ID: 27376889
[TBL] [Abstract][Full Text] [Related]
11. Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.
Orlovskiy S; Gupta PK; Roman J; Arias-Mendoza F; Nelson DS; Koch CJ; Narayan V; Putt ME; Nath K
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611062
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.
Stuparu AD; Capri JR; Meyer CAL; Le TM; Evans-Axelsson SL; Current K; Lennox M; Mona CE; Fendler WP; Calais J; Eiber M; Dahlbom M; Czernin J; Radu CG; Lückerath K; Slavik R
J Nucl Med; 2021 Jul; 62(7):989-995. PubMed ID: 33277393
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway.
Chuang HY; Lee YP; Lin WC; Lin YH; Hwang JJ
Sci Rep; 2019 Sep; 9(1):13284. PubMed ID: 31527721
[TBL] [Abstract][Full Text] [Related]
14. mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.
Simone CB; John-Aryankalayil M; Palayoor ST; Makinde AY; Cerna D; Falduto MT; Magnuson SR; Coleman CN
Transl Oncol; 2013; 6(5):573-85. PubMed ID: 24151538
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization in prostate cancer: mechanisms and targets.
Palacios DA; Miyake M; Rosser CJ
BMC Urol; 2013 Jan; 13():4. PubMed ID: 23351141
[TBL] [Abstract][Full Text] [Related]
16. Tissue biomarkers for prostate cancer radiation therapy.
Tran PT; Hales RK; Zeng J; Aziz K; Salih T; Gajula RP; Chettiar S; Gandhi N; Wild AT; Kumar R; Herman JM; Song DY; DeWeese TL
Curr Mol Med; 2012 Jul; 12(6):772-87. PubMed ID: 22292443
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model.
Lee YJ; Chung JK; Kang JH; Jeong JM; Lee DS; Lee MC
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):235-41. PubMed ID: 19727716
[TBL] [Abstract][Full Text] [Related]
18. Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?
Rosser CJ; Gaar M; Porvasnik S
BMC Cancer; 2009 Jul; 9():225. PubMed ID: 19589167
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.
Amano T; Nakamizo A; Mishra SK; Gumin J; Shinojima N; Sawaya R; Lang FF
J Neurooncol; 2009 May; 92(3):357-71. PubMed ID: 19357962
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis.
Nakamizo A; Amano T; Zhang W; Zhang XQ; Ramdas L; Liu TJ; Bekele BN; Shono T; Sasaki T; Benedict WF; Sawaya R; Lang FF
Neuro Oncol; 2008 Jun; 10(3):275-91. PubMed ID: 18443131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
